Global cancer in women: burden and trends
This review is an abbreviated version of a report prepared for the American Cancer Society
Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt …
Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt …
Quality of life in “chronic” cancer survivors: a meta-analysis
J Firkins, L Hansen, M Driessnack… - Journal of Cancer …, 2020 - Springer
Purpose Cancer survivors are now living longer giving rise to a new concept—chronic
cancer as survivors continue to face long-term consequences of cancer and its treatment …
cancer as survivors continue to face long-term consequences of cancer and its treatment …
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer: American College of …
A Brunelli, AW Kim, KI Berger, DJ Addrizzo-Harris - Chest, 2013 - Elsevier
Background This section of the guidelines is intended to provide an evidence-based
approach to the preoperative physiologic assessment of a patient being considered for …
approach to the preoperative physiologic assessment of a patient being considered for …
Guidelines on the radical management of patients with lung cancer
A joint initiative by the British Thoracic Society and the Society for Cardiothoracic Surgery in
Great Britain and Ireland was undertaken to update the 2001 guidelines for the selection …
Great Britain and Ireland was undertaken to update the 2001 guidelines for the selection …
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines
GL Colice, S Shafazand, JP Griffin, R Keenan… - Chest, 2007 - Elsevier
Background This section of the guidelines is intended to provide an evidence-based
approach to the preoperative physiologic assessment of a patient being considered for …
approach to the preoperative physiologic assessment of a patient being considered for …
Exercise training undertaken by people within 12 months of lung resection for non‐small cell lung cancer
V Cavalheri, C Burtin, VR Formico… - Cochrane Database …, 2019 - cochranelibrary.com
Background Decreased exercise capacity and health‐related quality of life (HRQoL) are
common in people following lung resection for non‐small cell lung cancer (NSCLC) …
common in people following lung resection for non‐small cell lung cancer (NSCLC) …
Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: a systematic review
H Poghosyan, LK Sheldon, SG Leveille, ME Cooley - Lung cancer, 2013 - Elsevier
INTRODUCTION: Surgical resection currently is the best available treatment to enhance
long-term survival after non-small cell lung cancer (NSCLC). With the anticipated growth in …
long-term survival after non-small cell lung cancer (NSCLC). With the anticipated growth in …
Evaluation of an early exercise intervention after thoracotomy for non-small cell lung cancer (NSCLC), effects on quality of life, muscle strength and exercise tolerance …
G Arbane, D Tropman, D Jackson, R Garrod - Lung cancer, 2011 - Elsevier
Deterioration in exercise tolerance and impairment in quality of life (QoL) are common
consequences of lobectomy. This study evaluates additional exercise and strength training …
consequences of lobectomy. This study evaluates additional exercise and strength training …
[HTML][HTML] Quality of life in NSCLC survivors—a multicenter cross-sectional study
M Hechtner, M Eichler, B Wehler, R Buhl… - Journal of Thoracic …, 2019 - Elsevier
Introduction The objective was to assess quality of life (QoL) in lung cancer survivors,
compare it to the general population, and identify factors associated with global QoL …
compare it to the general population, and identify factors associated with global QoL …
Safety and patient-reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab versus bevacizumab plus chemotherapy in non–small-cell …
M Reck, T Wehler, F Orlandi, N Nogami… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Atezolizumab, bevacizumab, carboplatin, and paclitaxel (ABCP) demonstrated
survival benefit versus bevacizumab, carboplatin, and paclitaxel (BCP) in chemotherapy …
survival benefit versus bevacizumab, carboplatin, and paclitaxel (BCP) in chemotherapy …